Demyelinating Disorders of the CNS

Demyelinating diseases result in damage to the myelin sheath that surrounds nerves in the brain and spinal cord and can result in neurological conditions such as multiple sclerosis. Here is the latest research on demyelinating disorders of the central nervous system.

September 21, 2021

Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patients.

Multiple Sclerosis and Related Disorders
Alexis A LizarragaKhema Sharma
September 17, 2021

Marchiafava-Bignami disease in a patient with schizophrenia and alcohol use disorder.

Actas españolas de psiquiatría
Julia Buesa-Lorenzo Buesa-LorenzoLuis Rojo-Moreno
September 16, 2021

A case of unilateral recurrent nerve palsy with chronic inflammatory demyelinating polyradiculoneuropathy.

Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
Taro KomachiMasanori Sakamaki
September 16, 2021

[Paroxysmal dysarthria and ataxia - unusual MS manifestation].

Läkartidningen
Chrysostomos PapastergiosFelicia Morar
September 16, 2021
Case Report
Open Access

Ixekizumab for Patients with Plaque Psoriasis Affected by Multiple Sclerosis: Case report.

Sultan Qaboos University Medical Journal
Enrique Herrera-AcostaEnrique Herrera-Ceballos
September 15, 2021
Case Report

Rare case of diffuse large B-cell lymphoma presenting with central pontine myelinolysis.

BMJ Case Reports
Phillip Cuong NguyenMichael Sze Yuan Low
September 14, 2021
Review

Carbohydrate and lipid metabolism in multiple sclerosis: Clinical implications for etiology, pathogenesis, diagnosis, prognosis, and therapy.

Archives of Biochemistry and Biophysics
Somayeh PashaeiMohammad Sajad Emami Aleagha
September 14, 2021

Cognitive impairment and depression in patients with relapsing-remitting multiple sclerosis depending on age and neuroimaging findings.

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Oksana O Kopchak, Tetiana A Odintsova
September 13, 2021
Review

Pathogenic antibodies to AQP4: Neuromyelitis optica spectrum disorder (NMOSD).

Biochimica Et Biophysica Acta. Biomembranes
Sukhvir K WrightAngela Vincent
September 10, 2021
Review

Emerging deep learning techniques using magnetic resonance imaging data applied in multiple sclerosis and clinical isolated syndrome patients (Review).

Experimental and Therapeutic Medicine
Eleftherios E KontopodisKostas Marias
September 10, 2021

The expression and prognostic value of miR-146a and miR-155 in Turkish patients with multiple sclerosis.

Neurological Research
Furkan SaridasOzlem Taskapilioglu
September 10, 2021
Open Access

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE.

International Journal of Molecular Sciences
Ranjithkumar RajendranMartin Berghoff
September 9, 2021

Critical Role of Astrocyte NAD+ Glycohydrolase in Myelin Injury and Regeneration.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Monica R LangleyIsobel A Scarisbrick

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/demyelinating-disorders-of-the/f3401b34-15d6-4a3b-8698-9dd5be1be8bf